Zurich Cantonal Bank
CPRX

Zurich Cantonal Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Zurich Cantonal Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
52,373
-601
-1% -$17.7K ﹤0.01% 1245
2026
Q1 		$1.31M Buy
+52,974
New +$1.26M ﹤0.01% 1275
2025
Q4 		– Sell
-37,894
Closed -$844K – 2790
2025
Q3 		$747K Buy
37,894
+6,004
+19% +$123K ﹤0.01% 1479
2025
Q2 		$692K Sell
31,890
-7
-0% -$165 ﹤0.01% 1453
2025
Q1 		$774K Buy
31,897
+3,244
+11% +$73.1K ﹤0.01% 1326
2024
Q4 		$598K Buy
28,653
+3,573
+14% +$76.8K ﹤0.01% 1521
2024
Q3 		$499K Buy
25,080
+388
+2% +$7.19K ﹤0.01% 1563
2024
Q2 		$382K Hold
24,692
– – ﹤0.01% 1671
2024
Q1 		$394K Hold
24,692
– – ﹤0.01% 1631
2023
Q4 		$415K Hold
24,692
– – ﹤0.01% 1626
2023
Q3 		$289K Buy
24,692
+5,044
+26% +$67.5K ﹤0.01% 1727
2023
Q2 		$264K Hold
19,648
– – ﹤0.01% 1734
2023
Q1 		$326K Buy
19,648
+4,425
+29% +$73K ﹤0.01% 1564
2022
Q4 		$283K Buy
15,223
+5,983
+65% +$92.1K ﹤0.01% 1607
2022
Q3 		$119K Hold
9,240
– – ﹤0.01% 2081
2022
Q2 		$65K Sell
9,240
-7,295
-44% -$53.5K ﹤0.01% 2475
2022
Q1 		$137K Buy
16,535
+8,258
+100% +$58.4K ﹤0.01% 2127
2021
Q4 		$56K Buy
8,277
+1,373
+20% +$9.03K ﹤0.01% 2702
2021
Q3 		$37K Hold
6,904
– – ﹤0.01% 2700
2021
Q2 		$40K Hold
6,904
– – ﹤0.01% 2498
2021
Q1 		$32K Hold
6,904
– – ﹤0.01% 2490
2020
Q4 		$23K Hold
6,904
– – ﹤0.01% 2565
2020
Q3 		$21K Hold
6,904
– – ﹤0.01% 2486
2020
Q2 		$32K Hold
6,904
– – ﹤0.01% 2342
2020
Q1 		$27K Hold
6,904
– – ﹤0.01% 2232
2019
Q4 		$26K Hold
6,904
– – ﹤0.01% 2430
2019
Q3 		$37K Buy
6,904
+595
+9% +$3.17K ﹤0.01% 2213
2019
Q2 		$24K Buy
+6,309
New +$27.3K ﹤0.01% 2411

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zurich Cantonal Bank's CPRX Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Catalyst Pharmaceutical (CPRX) stake by 1.1% in Q2 2026, selling an estimated $17.7K and leaving 52,373 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Zurich Cantonal Bank first reported a position in CPRX in Q2 2019 and has held it in 28 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Zurich Cantonal Bank held 52,373 shares of Catalyst Pharmaceutical worth $1.65M as of Q2 2026.
  • Zurich Cantonal Bank sold 601 Catalyst Pharmaceutical shares in Q2 2026, an estimated $17.7K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1245 holding.
  • Zurich Cantonal Bank first reported a position in Catalyst Pharmaceutical in Q2 2019 and has held it in 28 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.